July 28, 2020

Professor Dressler on Botulinum Toxin Therapy in the Times of Corona

We talked to Prof Dressler how the Corona crisis has affected dystonia patients in Germany but also in other countries. Q: Professor Dressler, the Corona crisis has severely affected botulinum toxin therapy. What happened? Dressler: During the Corona crisis the access to many routine medical services were restricted  or even completely blocked. This also happened…

Show this Post ›
July 13, 2020

Survey on Impact of COVID-19 Pandemic on Symptoms, Activity and Quality of Life in People Living with Dystonia.

Associate Professor Lynley Bradnam, Dr Rebecca Meiring, Dr Silmara Gusso, research assistant Tia Lindbom, Department of Exercise Sciences, University of Auckland, invite you take part in an anonymous survey investigating the impact of COVID-19 pandemic on symptoms, activity and quality of life in people living with Dystonia. You are eligible to take part if you have…

Show this Post ›
July 8, 2020

Launch of European Dystonia Research Consortium: EurDyscover

On Tuesday 7 July the kick-off meeting of the EurDyscover Consortium took place on Zoom. Coordinator is the University Hospital of Würzburg, Neurology department, and Jens Volkmann and Chi Wang Ip. Other partners in the consortium are: • Antonio Pisani, IRCCS Fondazione Santa Lucia, Laboratory of Neurophysiology and Plasticity, Rome, Italy • Albino Oliveira-Maia, Fundação…

Show this Post ›
June 30, 2020

EFNA Webinar – Where´s Neurology? Influencing Covid Recovery Planning, Programmes and Policies’ 

On the 30th June Dystonia Europe participated in «Where´s Neurology?», a webinar held by  EFNA (European  Federation for Neurology Associations). The webinar is a part of a series to discuss how  EFNA can ensure that our voices are heard and integrated in the post-pandemic recovery planning phase, including the development of policies and programmes. EFNA…

Show this Post ›